Mi Cancer Seek
Payments companies reported to CMS as associated with Mi Cancer Seek. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mi Cancer Seek, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mi Cancer Seek
These are the largest totals companies reported as associated with Mi Cancer Seek. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ali Nael Amzajerdi | Newport Beach, CA | Anatomic Pathology & Clinical Pathology | $66,825.00 |
| Gaurav Singal | Boston, MA | Internal Medicine | $45,000.00 |
| Matthew Anderson | Tampa, FL | Obstetrics & Gynecology | $4,485.49 |
| Kristen Spencer | New Brunswick, NJ | Medical Oncology | $1,750.00 |
| Misako Nagasaka | Orange, CA | Hematology & Oncology | $1,700.00 |
| Justin Moser | Scottsdale, AZ | Internal Medicine | $1,689.83 |
| Sonikpreet Aulakh | Morgantown, WV | Hematology & Oncology | $1,350.00 |
| Sean Warsch | Asheville, NC | Hematology & Oncology | $1,167.48 |
| Eric Luk | Asheville, NC | Hematology & Oncology | $1,157.19 |
| Wieslawa Pekal | Asheville, NC | Hematology & Oncology | $1,140.99 |
Prescribed Mi Cancer Seek?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.